22nd February 2019
Latest news
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
13th February 2019
Campaign to Support FDA Approved Products
5th February 2019
Curium Petten and NRG Agreement
9th January 2019
RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate.
3rd January 2019
Curium and Progenics Announce European Collaboration for Prostate Cancer Imaging Agent PyL™
6th September 2018
Curium’s Renaud Dehareng recognized with CEO Healthcare Award 2018
27th August 2018
Curium and RadioMedix Announce Exclusive Global Agreement for 64Cu-Dotatate Development
10th May 2018
Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas
2nd May 2018
Curium enhances its position in the French PET market with the completion of the acquisition of Cyclopharma’s French commercial and manufacturing operations
11th April 2018
Curium to acquire the French commercial and manufacturing operations of Cyclopharma
26th March 2018
Moving on from Mallinckrodt: Curium eyes $650 million in radiopharmaceuticals sales
10th February 2018
Curium is attending these global congresses in 2018
28th January 2018
Curium One-Year Anniversary Marked by Landmark Achievements
16th January 2018
Curium Is the First North American Manufacturer Offering Exclusively 100% LEU Generators
18th December 2017
Curium’s Renaud Dehareng receives top USA CEO award 2017!
1st September 2017
“Growth in isotope market” – Curium featured in North-Holland newspaper
26th June 2017
Panel of Mo-99 producers say supplies are secure, outline investments made to bolster future of supply. Panel convenes at Nuclear Medicine meeting in Denver
6th April 2017
IBA Molecular and Mallinckrodt Nuclear Medicine LLC to create a new, world-class radiopharmaceutical company: Curium
27th January 2017
IBA Molecular acquires Mallinckrodt Nuclear Imaging to create world-class radiopharmaceuticals Group
24th August 2016